CJC-1295 (no DAC)

Lot CP-CJC129YQ-2602C · 10 mg

99.21 %

HPLC purity

Spec ≥ 99.0 %

88.6 %

Net peptide content

By amino acid analysis

< 0.45

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory: Janoshik Analytical
Accreditation: ISO/IEC 17025:2017
Country of synthesis: United States
Manufactured: Feb 7, 2026
Release tested: Feb 16, 2026 (7 months ago)
Retest date: Feb 7, 2028
CAS number: 863288-34-0
Molecular formula: C152H252N44O42
Theoretical mass: 3367.90 Da
Observed mass (LC-MS): 3367.90 Da (Δ 0.00 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
Method	Parameter	Specification	Result
RP-HPLC (UV 214 nm)	Purity (area %)	≥ 99.0 %	99.21 %	Pass
LC-MS (ESI+)	Identity — observed mass	3367.90 ± 1.0 Da	3367.90 Da	Pass
Amino acid analysis	Net peptide content	≥ 80.0 %	88.6 %	Pass
Karl Fischer	Water content	≤ 8.0 %	4.97 %	Pass
Ion chromatography	Residual TFA	≤ 1.0 %	0.31 %	Pass
LAL kinetic chromogenic	Bacterial endotoxin	< 5.0 EU/mg	< 0.45 EU/mg	Pass
USP <71> membrane filtration	Sterility	No growth	No growth	Pass
Visual / USP <790>	Appearance	White to off-white cake, free of visible particulates	Conforms	Pass

Handling for this lot

Appearance: White lyophilised powder
Storage: -20 °C lyophilised, protected from light
Reconstitution: Swirl gently; avoid vigorous mixing which promotes aggregation in this 29-mer.

Other lots of CJC-1295 (no DAC)

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.